Failing to fund the global fight against COVID-19 is a choice to extend the pandemic,
to accept preventable suffering and insecurity for all,
and to live with the knowledge that, deep in the time of the world’s greatest need, the United States gave up.
SCOOP: Lawmakers have agreed on deal for $10 billion in US covid funds, set to be announced today — but have *dropped* funding for global response, people familiar tell me and @rachel_roubein.
https://t.co/ev1dAr5e7U
We also are working with African & global experts to support countries speaking up about unfair terms. Countries need these health agreements after the cuts. But that doesn't mean we accept Trump’s extractivism or his efforts to divide & conquer the partners of the United States.
We spoke w/ WSJ’s @caroline__kimeu for this excellent piece about African states standing up to Trump’s extractive deals. "Public Citizen has sued the State Department in an effort to force release of the details. The federal suit is pending.”
https://t.co/MgyhD28v6T
"… The Trump administration has kept details of the proposed agreements—and even signed accords—secret, although some apparent drafts have circulated online.”
The clock is ticking on these funds.
The $600 million Congress appropriated for Gavi, the Vaccine Alliance, expires September 30.
Rubio claims State is "reengaging", but that's not disbursement.
Children don't get vaccinated by a reengagement process. Release the funds now.
CMS Admin Dr. Oz repeats unsubstantiated claims of the savings Trump's drug pricing plans have achieved at White House presser today. Don't just repeat their claim. More info here: https://t.co/RxSpJMXpPO
We are suing Trump’s State Dept to compel release of its “America First” health deals with developing nations.
Their strategy: divide & conquer the partners of the United States.
Ours: get the docs, tell the truth about what State expects, or extracts, from nations in return.
We are suing the State Department for failing to disclose health agreements with several African nations.
The government missed its FOIA deadline.
This secrecy doesn't just impact the public's right to know how the government is approaching assistance.
It may cost lives.
Trump's pharma tariffs: most companies are exempt in return for weak deals on pricing and manufacturing. In the few cases where drug companies aren’t exempted from the tariffs, the results could be higher medication prices for American patients.
https://t.co/TfBrFHAoFT
A breakthrough only matters if people can access it.
Lenacapavir is a promising new tool for HIV prevention — but its impact will depend on access, affordability, and sustained global commitment.
Join AHF’s Saba Sadat alongside Wesley Sundquist and Peter Maybarduk for a conversation on turning scientific progress into equitable access.
🗓 April 4 | 1:15–2:45 PM PT
📍 UCLA NRB Auditorium
Moderated by Cassidy Parshall
At the Universities Allied for Essential Medicines North American Conference 2026 @Public_Citizen
👉 Register here to attend: https://t.co/d3HP3bcSYj
Get a load of this S#$%:
Pfizer's CEO said European nations must pay even more for medicines or risk losing their supply.
Does he want to hold drugs hostage at the expense of human lives to make a little more money?
Pfizer must end this threat & take accountability for its high drug prices!
Fortunately, every country has the right to override the patent monopoly and authorize generics, if Big Pharma moves this way.
Not selling your patented product is called a working failure. It’s a classic use case for a compulsory license.
We wrote Pfizer CEO Albert Bourla to ask where he gets off threatening to withhold drugs from countries that need them.
“ Americans pay too much for drugs. But that is not France’s fault, or responsibility. It is yours.”
Americans aren’t going bankrupt from cancer b/c Europeans get the same meds for less. They are going broke so pharma CEOs can get their multi-million $ paydays, & they are going broke so pharma can enrich shareholders.
https://t.co/YSqiPpT6fr
Americans aren’t going bankrupt from cancer b/c Europeans get the same meds for less. They are going broke so pharma CEOs can get their multi-million $ paydays, & they are going broke so pharma can enrich shareholders.
https://t.co/YSqiPpT6fr
The Medicines for the People Act reclaims power that drug corporations abuse, to ensure we are supporting research and development that meets people’s medical needs at fair prices instead of publicly subsidizing pharma greed.
Big Pharma gets a large amount of taxpayer dollars, yet families still face outrageous drug prices. Our government must drive drug development, not leave it to companies that put profits before public health. The Medicines for the People Act will make new prescription drugs affordable and available to all.
The European industry’s own data indicates its member spent €55 billion on R&D in 2024 and took in €185 in payment from state health insurance systems for ambulatory care, which is an underestimate of total drug payments received in these countries.
https://t.co/wEoE4cu4wR
The White House still has not published any of its deals with drugmakers, making its claims to have lowered prices very difficult to believe.
But we know for a fact Trump & GOP gave pharma an $8+ billion payout out of pockets of taxpayers & cancer patients via the Big Ugly Bill.